Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Cash (2016 - 2025)

Historic Change in Cash for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $1.1 million.

  • Rockwell Medical's Change in Cash rose 13747.37% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 7222.1%. This contributed to the annual value of $6.7 million for FY2024, which is 69687.22% up from last year.
  • According to the latest figures from Q3 2025, Rockwell Medical's Change in Cash is $1.1 million, which was up 13747.37% from $1.1 million recorded in Q2 2025.
  • Rockwell Medical's 5-year Change in Cash high stood at $20.9 million for Q2 2022, and its period low was -$17.8 million during Q3 2022.
  • Its 5-year average for Change in Cash is -$1.8 million, with a median of -$1.9 million in 2023.
  • In the last 5 years, Rockwell Medical's Change in Cash skyrocketed by 73287.84% in 2022 and then tumbled by 39558.08% in 2024.
  • Rockwell Medical's Change in Cash (Quarter) stood at -$10.1 million in 2021, then surged by 71.53% to -$2.9 million in 2022, then soared by 142.53% to $1.2 million in 2023, then skyrocketed by 171.57% to $3.3 million in 2024, then plummeted by 66.06% to $1.1 million in 2025.
  • Its Change in Cash stands at $1.1 million for Q3 2025, versus $1.1 million for Q2 2025 and -$4.3 million for Q1 2025.